ICD-10 Code K77: Liver disorders in diseases classified elsewhere

Key Takeaways

ICD-10 Code K77 (Liver disorders in diseases classified elsewhere) is a billable, specific ICD-10-CM code valid for the 2026 fiscal year under the K70-K77 diseases of liver range.

K77 is a manifestation code: it describes a liver disorder caused by an underlying disease, not the underlying condition itself. Always code the primary etiology first.

Using K77 as a standalone code without a preceding etiology code violates ICD-10-CM sequencing rules and risks claim denial or audit flags.

Pabau’s claims management software helps coding teams sequence multi-code diagnoses correctly and flag incomplete etiology pairings before claims are submitted.

ICD-10 Code K77 represents “Liver disorders in diseases classified elsewhere,” meaning it documents hepatic involvement that occurs as a manifestation of a systemic or underlying disease rather than a primary liver pathology. According to the Centers for Medicare and Medicaid Services (CMS) ICD-10-CM code set, K77 sits within the K00-K95 chapter (Diseases of the Digestive System), subrange K70-K77 (Diseases of liver).

The World Health Organization originally established this classification to capture liver involvement that cannot be attributed to a primary hepatic disease. Certain systemic conditions affect multiple organ systems simultaneously. When the liver is one of those organ systems, K77 documents the hepatic manifestation while the primary code documents the root cause.

Billable status and code validity

K77 is a billable, specific ICD-10-CM code valid for reimbursement purposes for fiscal year 2026. It has been a valid billable code continuously since ICD-10-CM replaced ICD-9-CM for covered entities under HIPAA.

• Code system: ICD-10-CM (International Classification of Diseases, 10th Revision, Clinical Modification)
• Chapter: K00-K95, Diseases of the Digestive System
• Subrange: K70-K77, Diseases of liver
• Billable status: Billable/Specific Code (FY 2026)
• Pediatric applicability: Valid for patients ages 0-17 per ICD-10-CM tabular data
• Code type: Manifestation code (requires paired etiology code)

Inclusion terms (synonyms) under K77

The ICD-10-CM tabular list includes several inclusion terms under K77. These are conditions that map to this code when documented by the treating clinician.

• Alpha-1-antitrypsin hepatitis
• Blastomycosis of the liver
• Hepatic granulomas in schistosomiasis
• Sarcoidosis with liver involvement
• Toxoplasmosis hepatitis

This list is not exhaustive. Coders should check the CDC/NCHS ICD-10-CM web tool to verify current inclusion terms for the applicable fiscal year, since minor updates occur annually.

Etiology/manifestation coding convention for ICD-10 Code K77

The etiology/manifestation convention is the single most important coding rule governing K77. Getting this wrong is the primary cause of claim denials and documentation audit failures associated with this code.

Under ICD-10-CM Official Guidelines Section I.C, when a condition has both an underlying etiology and a body system manifestation, the etiology code is sequenced first and the manifestation code is sequenced second. K77 carries an explicit “Code First” instruction in the tabular list, which makes this sequencing mandatory, not discretionary. Ensuring HIPAA-mandated coding requirements are met means respecting this sequencing rule on every claim.

How the “code first” instruction works

When the tabular list shows “Code First” under K77, it means the coder must assign a code for the underlying disease before K77 on the claim. The underlying disease code drives MS-DRG grouping and reimbursement. K77 adds clinical specificity about the hepatic manifestation.

K77 should never appear as the first-listed or principal diagnosis code on a claim. If a coder submits a claim with K77 alone, most payers will reject it or flag it for medical necessity review. Practice teams can reduce these errors by implementing structured coding workflows through their claims management software.

Why the etiology code must come first

ICD-10-CM uses sequencing to communicate clinical hierarchy to payers. The first-listed code signals the primary reason for the encounter. When a patient presents with liver involvement secondary to sarcoidosis, the encounter is driven by the sarcoidosis, not by an isolated liver condition. Sequencing K77 first misrepresents the clinical picture and can trigger a claim denial or request for additional documentation.

Adjacent codes in the K70-K77 diseases of liver range

Understanding where ICD-10 Code K77 sits within the K70-K77 range helps coders select the right code when documentation is ambiguous or when multiple hepatic codes appear during a clinical encounter. The K70-K77 range covers all liver disease categories under Chapter 11.

K70–K74: Alcoholic, toxic, and structural liver diseases

• K70: Alcoholic liver disease (including fatty liver, hepatitis, fibrosis, cirrhosis, and failure)
• K71: Toxic liver disease (includes cholestasis, necrosis, hepatitis, and fibrosis from drug or toxic exposure)
• K72: Hepatic failure, not elsewhere classified (acute, subacute, chronic)
• K73: Chronic hepatitis, not elsewhere classified
• K74: Fibrosis and cirrhosis of liver (including primary biliary cirrhosis at K74.3)

K75–K77: Inflammatory and secondary liver disorders

• K75: Other inflammatory liver diseases (includes abscess, phlebitis of portal vein, granulomatous hepatitis)
• K76: Other diseases of liver (includes fatty degeneration, hepatic veno-occlusive disease, hepatorenal syndrome)
• K77: Liver disorders in diseases classified elsewhere (manifestation code requiring etiology first)

For accurate ICD-10 diagnostic code reference across this range, the AAPC Codify ICD-10-CM lookup provides current year descriptions, code notes, and hierarchical navigation. This is particularly useful when reviewing related codes in the same chapter during complex chart documentation, alongside internal ICD-10 diagnostic code reference resources.

K77 vs K76.9: choosing the correct code

K76.9 (Liver disease, unspecified) and K77 are the two codes most commonly confused in outpatient and inpatient documentation. Selecting the wrong one misrepresents the clinical picture and introduces coding risk.

The distinction comes down to whether a specific underlying disease is identified and documented. Reviewing how ICD-10 code crosswalk guidance handles similar manifestation-versus-unspecified decisions can help coders apply the same logic to K77.

K76.9 carries a Type 2 Excludes note in the tabular list. Coders should review these exclusion notes carefully, as they indicate conditions that should be coded separately rather than replaced by K76.9. K77 is not excluded by K76.9 and can coexist on a claim when both are clinically documented and correctly sequenced.

Reduce coding errors with Pabau

Pabau's claims management tools help practice teams flag incomplete diagnosis code pairings, sequence multi-code claims correctly, and track denial patterns before they compound. Less rework, cleaner claims.

Book a demo

Documentation requirements for ICD-10 Code K77

Strong documentation is what separates a clean K77 claim from a denial. Coders rely on what the clinician documents. When documentation is vague, coders cannot apply K77 correctly, and the result is either a query back to the provider or an inaccurate code assignment.

Maintaining accurate ICD-10 documentation standards across all diagnostic codes reduces audit exposure. For K77 specifically, the following documentation elements are required before the code can be applied.

What the clinician must document

• Named underlying disease: The clinician must explicitly identify the systemic or infectious condition causing the liver involvement. “Liver involvement” or “hepatic findings” without a named cause is not sufficient for K77.
• Causal relationship: Documentation must establish that the liver disorder is secondary to or caused by the named underlying disease. Phrases like “liver involvement due to sarcoidosis” or “hepatic granulomas in the setting of schistosomiasis” meet this standard.
• Clinical findings: Lab values (LFTs, liver enzymes), imaging results, or biopsy findings supporting liver involvement should be recorded to support medical necessity.
• Encounter reason: The primary reason for the encounter drives sequencing. If the patient is being managed for sarcoidosis and liver involvement is noted, the etiology code is first-listed.

Structured patient record documentation that captures etiology-manifestation relationships at the point of care reduces the volume of coder queries and speeds up the billing cycle. Digital tools that embed diagnosis code fields into clinical notes further reduce the gap between documentation and coding.

Outpatient vs inpatient documentation standards

The rules differ depending on care setting. Outpatient coders apply confirmed diagnoses only. If the clinician documents “suspected sarcoidosis with possible liver involvement,” an outpatient coder cannot assign K77. The coder would use the most specific code for the liver findings alone.

Inpatient coders follow different guidance. At discharge, probable and suspected conditions may be coded as if confirmed. A discharge summary stating “probable hepatic sarcoidosis” in an inpatient setting supports both the sarcoidosis etiology code and K77 as the manifestation. Coding teams using HIPAA-compliant clinic software can track these setting-specific rules through built-in documentation workflows.

Common underlying conditions that generate a K77 manifestation

Knowing which systemic diseases commonly produce hepatic manifestations helps coders anticipate K77 and proactively review documentation when these conditions appear on a claim.

Infectious and granulomatous diseases

Schistosomiasis (B65.x): One of the most common causes of K77 globally. The parasitic infection causes periportal fibrosis and granulomatous liver disease. Documentation should specify the schistosomiasis species when known.

Blastomycosis (B40.x): A fungal infection that disseminates to the liver in immunocompromised patients. An explicit statement of hepatic blastomycosis in the record supports K77 as the manifestation code.

Toxoplasmosis (B58.x): Hepatic involvement can occur in congenital toxoplasmosis and in immunocompromised adults. B58.1 (Toxoplasma hepatitis) is a specific manifestation code, but K77 applies when documentation does not distinguish the specific hepatic presentation and the clinician documents liver involvement due to toxoplasmosis.

Sarcoidosis (D86.x): Hepatic granulomas occur in 50-80% of patients with systemic sarcoidosis, according to the WHO ICD-10 classification. When liver involvement is documented alongside a sarcoidosis diagnosis, the etiology/manifestation pairing applies.

Metabolic and genetic conditions

Alpha-1-antitrypsin deficiency (E88.01): This genetic disorder causes progressive liver disease as misfolded proteins accumulate in hepatocytes. Alpha-1-antitrypsin hepatitis is an inclusion term directly under K77 in the tabular list, making this one of the clearest documentation scenarios for applying the code.

Supporting clinical documentation for these cases benefits from structured intake processes. Digital intake forms that capture family history and prior diagnoses give clinicians the data they need to document genetic etiology clearly at the point of care.

ICD-10 Code K77 billing and payer considerations

K77 does not carry a standalone MS-DRG assignment because it is a manifestation code. MS-DRG grouping is driven by the principal diagnosis, which is the etiology code. The MS-DRG version that applies depends on the discharge date and the CMS fiscal year grouper in use at the time of the encounter.

For inpatient claims, the MS-DRG associated with the underlying disease (sarcoidosis, schistosomiasis, alpha-1-antitrypsin deficiency) determines the payment rate. K77 contributes to complexity and severity documentation, which may influence CC/MCC status and DRG assignment depending on the grouper logic.

Payer-specific considerations

Payer policies on manifestation codes vary. Medicare follows CMS ICD-10-CM sequencing guidelines strictly. Commercial payers may have additional requirements around supporting documentation or prior authorization for the underlying condition.

• Never submit K77 alone. Most clearinghouses and payer edit systems will reject a claim with an isolated manifestation code.
• Confirm the etiology code is valid for the FY. CMS releases updated code lists annually. Verify through the CMS ICD-10-CM code set.
• Document specificity for the underlying disease. Using the most specific available etiology code improves MS-DRG accuracy and reduces the risk of a medical necessity query.
• Track denial patterns. If K77 claims are denying repeatedly, the root cause is almost always a documentation gap in the etiology field rather than a problem with K77 itself.

Teams managing clinical documentation best practices at scale benefit from workflows that flag incomplete etiology-manifestation pairings before a claim leaves the practice. This is especially important for high-volume gastroenterology and hepatology practices where K77 may appear frequently.

Conclusion

ICD-10 Code K77 is a billable manifestation code for liver disorders in diseases classified elsewhere. It requires mandatory etiology code sequencing, specific documentation of the underlying condition, and awareness of the outpatient versus inpatient coding standards that govern when it applies. The most common failure point is submitting K77 without a preceding etiology code, which guarantees a denial or audit query.

Pabau’s claims management software helps practices build the coding workflows that prevent these errors before they reach the payer. To see how Pabau supports accurate diagnosis coding and cleaner claim submissions, book a demo with the team.

Continue your research

Need a complete overview of ICD-10-CM diagnostic code documentation? Situational anxiety ICD-10 code walks through a similar manifestation-versus-primary-code distinction in mental health coding.

Managing multi-code claims across a practice? Claims management software from Pabau helps teams track diagnosis code pairings and reduce denial rates.

Want to tighten your clinical documentation workflows? Medical forms at your healthcare practice covers how structured digital forms reduce coder queries and improve code accuracy at the point of care.

Frequently Asked Questions